News headlines about AllianceBernsteinome Fund (NYSE:ACG) have been trending somewhat positive recently, according to Accern. The research firm identifies positive and negative press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. AllianceBernsteinome Fund earned a coverage optimism score of 0.07 on Accern’s scale. Accern also gave press coverage about the investment management company an impact score of 45.9014472961456 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
AllianceBernsteinome Fund (ACG) traded down 0.13% during trading on Friday, hitting $7.91. 2,317,017 shares of the company’s stock traded hands. The firm’s 50-day moving average price is $7.82 and its 200 day moving average price is $7.80. AllianceBernsteinome Fund has a 12-month low of $7.41 and a 12-month high of $8.05.
AllianceBernsteinome Fund Company Profile
AllianceBernstein Income Fund, Inc (the Fund) is a diversified, closed-end management investment company. The investment objective of the Fund is high current income consistent with preservation of capital. The Fund invests its net assets in income-producing securities. The Fund invests its total assets in securities issued or guaranteed by the United States Government, its agencies or instrumentalities, and repurchase agreements pertaining to the United States Government securities.
What are top analysts saying about AllianceBernstein Income Fund Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for AllianceBernstein Income Fund Inc and related companies.